Activated platelets secrete LPA and CLEC, which enhance the invasive ability of osteosarcoma through the LPA-LPAR1 axis and the interaction between platelet CLEC-2 and osteosarcoma podoplanin (37, 38). Here, LPAR1 is linked to osteosarcoma.